Sodium Chloride
RxNorm 1807628· SODIUM CHLORIDE· INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Hospira, Inc.
Indications and usage
INDICATIONS AND USAGE This parenteral preparation is indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.
Dosage and administration
DOSAGE AND ADMINISTRATION The volume of the preparation to be used for diluting or dissolving any drug for injection, is dependent on the vehicle concentration, dose and route of administration as recommended by the manufacturer. This parenteral should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
Adverse events
Most frequently reported events (FDA FAERS). Report frequency does not imply causation.
- drug ineffective17,506
- off label use17,103
- fatigue14,002
- nausea13,600
- death13,261
- dyspnoea12,671
- diarrhoea11,465
- headache11,175
- vomiting10,977
- pyrexia10,833
- pain10,293
- seizure9,986
- pneumonia9,553
- rash8,097
- dizziness8,080
- asthenia7,975
Adverse reactions (label)
ADVERSE REACTIONS Reactions which may occur because of this solution, added drugs or the technique of reconstitution or administration include febrile response, local tenderness, abscess, tissue necrosis or infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection and extravasation. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate countermeasures, and if possible, retrieve and save the remainder of the unused vehicle for examination.
View more: Full FDA label on DailyMed →Label effective 20241106